NCT05963217
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
NCT07555470
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
- Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China
NCT07628738
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
Recruiting
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
NCT04892277
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Recruiting
CAYA Cancer Prospective Cohort Study
NCT07632014
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Cancer, Hematologic Diseases, +12 more
- Locations
-
- Yeolyan Center for Cancer and Blood Disorders Yerevan, Armenia
- The Children's Cancer Hospital Egypt 57357 Cairo, Egypt
- Unidad Nacional de Oncología Pediátrica (UNOP) Guatemala City, Guatemala
NCT05891821
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Hematology Center named after prof. R. Yeolyan Yerevan, Armenia
NCT07200102
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Recruiting
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
NCT07234162
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Anhui Provincial Cancer Hospital Hefei, Anhui, China
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Beijing Tongren Hospital, CMU Beijing, Beijing Municipality, China
NCT05776979
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT07018050
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China